EBITDA₹76.90 Cr
Q2 FY27SOLARA · What Changed
What Changed at
Solara Active Pharma Sciences Limited?
See reported financial changes and material NSE disclosures for Solara Active Pharma Sciences Limited.
My CompaniesSaved on this device. No account needed.
Follow a company to build your personal change feed.
Latest company changes
Solara Active Pharma Sciences Limited
Start with what changed, then open the supporting financial and operating detail only when you need it.
Latest reported changes
What Changed
Worth reviewing
Neutral / mixed
NSE disclosure · 16 Oct 2026
Capital
The company allotted Securities Alteration Of Capital and Fund Ra.
+
Worth reviewing
Neutral / mixed
NSE disclosure · 16 Oct 2026
Capital
The company granted 470000 Options under Solara Employee Stock Option Plan 2024. ESOP/ESOS/ESPS.
+
Showing 1–2 of 2 recorded updates from the past 90 days
Financial snapshot
Latest Reported Financials
Available reported figures from the latest period.
EPS₹5.90
Q2 FY27Today
Loading today’s changes…Today on Nivata
— meaningful changes— companies
Checking the latest tracked company developments…